PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This randomized trial will evaluate the efficacy and safety of PRGN-2009 in combination with pembrolizumab compared to pembrolizumab alone in patients with pembrolizumab-resistant recurrent or metastatic cervical cancer.
Epistemonikos ID: 9548f3fbb0c1d6062ba3fad11689ae85627e6272
First added on: May 15, 2024